Collaborations & Alliances
Related Searches:
Filter by:
601 - 615 of 1104 results
May 24, 2010
Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs.
Read More »
May 21, 2010
Ablynx and Pfizer have extended their research collaboration and license agreement to discover and develop Nanobody-based therapeutics against tumor necrosis factor alpha (TNF-alpha), for another year.
Read More »
May 19, 2010
Evotec AG has advanced a compound in its strategic alliance with Boehringer Ingelheim into Phase I clinical studies.
Read More »
May 18, 2010
Columbia Laboratories, Inc. has renewed its license and supply agreement with Merck Serono for Crinone (progesterone gel) for an additional five years.
Read More »
May 10, 2010
Evotec AG has entered into a multi-year integrated drug discovery alliance with Genentech to discover novel small molecule therapeutics.
Read More »
May 10, 2010
Tekmira Pharmaceuticals Corp. has entered into a multi-year target validation agreement with Bristol-Myers Squibb.
Read More »
May 6, 2010
Merck has restructured its co-development and commercialization agreement with Ariad Pharmaceuticals, Inc., obtaining an exclusive license to ridaforolimus, an investigational, oral mTOR inhibitor in development for the treatment of multiple types of can
Read More »
May 5, 2010
Boehringer Ingelheim and Micromet, Inc. have entered into a collaboration agreement for the research, development and commercialization of a new BiTE antibody for the treatment of multiple myeloma.
Read More »
May 4, 2010
Vetter, a provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have signed a preferred partnership agreement.
Read More »
April 29, 2010
Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a provider of clinical cell line development services, have entered into a collaboration agreement to create a business model enabling customers to access the
Read More »
April 26, 2010
Avecia Biotechnology has entered an agreement with Pfizer for the commercial supply of a key component of Pfizer’s Macugen (pegaptanib sodium injection).
Read More »
April 21, 2010
Will test screening samples on JNK kinases
Read More »
April 20, 2010
Deal could reach $467 million, plus royalties, if all milestones are achieved.
Read More »
April 20, 2010
ADC collaboration continues with payment
Read More »
April 15, 2010
XOMA Ltd. has received a $1 million milestone payment from Takeda Pharmaceutical Co. Ltd. for achieving a preclinical milestone under the companies' 2006 collaboration agreement.
Read More »
601 - 615 of 1104 results
